As one of the leading health research institutes in Canada, Lawson has many stories to tell. Search through our Latest News to find out about important medical breakthroughs, major announcements and research publications, new clinical trials, industry partnerships, commercialization developments and more.
Our Events calendar includes a variety of research, industry and foundation listings You can also find out more about Lawson’s signature events:
Neurofeedback, also called ‘brain training,’ consists of exercises where individuals regulate their own brain activity. In a new study from Lawson Health Research Institute and Western University, researchers have found that neurofeedback may be an effective treatment for individuals with post-traumatic stress disorder (PTSD).
During a virtual event for Londoners hosted by Lawson Health Research Institute and the City of London, a multi-sectoral research team announced two projects representing a collaborative approach to preventing homelessness from within hospital walls.
Built on the unique and successful No Fixed Address (NFA) strategy, these projects are being tested as a potential best practice for preventing hospital discharge to homelessness.
A Canadian consortium, which includes Lawson Health Research Institute (Lawson), TRIUMF, BC Cancer and Centre for Probe Development and Commercialization, is the first in the world to receive regulatory approval to produce the world’s most commonly used medical isotope, technetium-99m (Tc-99m), using small particle accelerators known as cyclotrons.